Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 6024-6034

  José, Ricardo J ^a   Williams, Andrew E ^a   Mercer, Paul F ^a   Sulikowski, Michal G ^a   Brown, Jeremy S ^a   Chambers, Rachel C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN ANTITHROMBIN COMPLEX; VORAPAXAR; AUTACOID; CHEMOKINE; CYTOKINE;

ALVEOLAR BARRIER DISRUPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME REGULATION; FEMALE; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD CLOTTING; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOTAXIS; DISEASE MODEL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG ALVEOLUS; METABOLISM; MICROBIOLOGY; PATHOLOGY; PERMEABILITY; STREPTOCOCCUS PNEUMONIA;

ANIMALS; BLOOD COAGULATION; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CHEMOTAXIS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HOST-PATHOGEN INTERACTIONS; INFLAMMATION MEDIATORS; MICE; NEUTROPHILS; PERMEABILITY; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PULMONARY ALVEOLI; RECEPTOR, PAR-1; STREPTOCOCCUS PNEUMONIAE;

EID: 84931403755     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500124     Document Type: Article

References (57)

1. Mizgerd, J. P. 2006. Lung infection - a public health priority. PLoS Med. 3: e76. Available at: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030076.
2. Armstrong, G. L., L. A. Conn, and R. W. Pinner. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281: 61-66.
3. World Health Organisation. 2007. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly. Epidemiol. Rec. 82: 93-104.
4. Calbo, E., M. Alsina, M. Rodríguez-Carballeira, J. Lite, and J. Garau. 2010. The impact of time on the systemic inflammatory response in pneumococcal pneumonia. Eur. Respir. J. 35: 614-618.
5. Choi, G., J.-J. H. Hofstra, J. J. T. H. Roelofs, A. W. Rijneveld, P. Bresser, J. S. van der Zee, S. Florquin, T. van der Poll, M. Levi, and M. J. Schultz. 2008. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit. Care Med. 36: 204-210.
6. Kellum, J. A., L. Kong, M. P. Fink, L. A. Weissfeld, D. M. Yealy, M. R. Pinsky, J. Fine, A. Krichevsky, R. L. Delude, and D. C. Angus, GenIMS Investigators. 2007. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch. Intern. Med. 167: 1655-1663.
7. Picard, C., A. Puel, M. Bonnet, C.-L. Ku, J. Bustamante, K. Yang, C. Soudais, S. Dupuis, J. Feinberg, C. Fieschi, et al. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079.
8. von Bernuth, H., C. Picard, Z. Jin, R. Pankla, H. Xiao, C.-L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
9. Singh, S., A. V. Amin, and Y. K. Loke. 2009. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch. Intern. Med. 169: 219-229.
10. Herbold, W., R. Maus, I. Hahn, N. Ding, M. Srivastava, J. W. Christman, M. Mack, J. Reutershan, D. E. Briles, J. C. Paton, et al. 2010. Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection. Infect. Immun. 78: 2620-2630.
11. Abraham, E. 2003. Neutrophils and acute lung injury. Crit. Care Med. 31(4, Suppl.): S195-S199.
12. Lax, S., M. R. Wilson, M. Takata, and D. R. Thickett. 2014. Using a noninvasive assessment of lung injury in a murine model of acute lung injury. BMJ Open Respir Res 1: e000014. Available at: http://bmjopenrespres.bmj.com/content/1/1/e000014.full.
13. Chambers, R. C., and C. J. Scotton. 2012. Coagulation cascade proteinases in lung injury and fibrosis. Proc. Am. Thorac. Soc. 9: 96-101.
14. José, R. J., A. E. Williams, and R. C. Chambers. 2014. Proteinase-activated receptors in fibroproliferative lung disease. Thorax 69: 190-192.
15. Howell, D. C. J., R. H. Johns, J. A. Lasky, B. Shan, C. J. Scotton, G. J. Laurent, and R. C. Chambers. 2005. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am. J. Pathol. 166: 1353-1365.
16. Mercer, P. F., A. E. Williams, C. J. Scotton, R. J. José, M. Sulikowski, J. D. Moffatt, L. A. Murray, and R. C. Chambers. 2014. Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation. Am. J. Respir. Cell Mol. Biol. 50: 144-157.
17. Chackalamannil, S., Y. Wang, W. J. Greenlee, Z. Hu, Y. Xia, H.-S. Ahn, G. Boykow, Y. Hsieh, J. Palamanda, J. Agans-Fantuzzi, et al. 2008. Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J. Med. Chem. 51: 3061-3064.
18. Ramachandran, R. 2012. Developing PAR1 antagonists: minding the endothelial gap. Discov. Med. 13: 425-431.
19. Zhang, C., Y. Srinivasan, D. H. Arlow, J. J. Fung, D. Palmer, Y. Zheng, H. F. Green, A. Pandey, R. O. Dror, D. E. Shaw, et al. 2012. High-resolution crystal structure of human protease-activated receptor 1. Nature 492: 387-392.
20. Brown, J. S., T. Hussell, S. M. Gilliland, D. W. Holden, J. C. Paton, M. R. Ehrenstein, M. J. Walport, and M. Botto. 2002. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. USA 99: 16969-16974.
21. Wilson, R., J. M. Cohen, R. J. Jose, C. de Vogel, H. Baxendale, and J. S. Brown. 2014. Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses. Mucosal Immunol. 10.1038/mi.2014.95.
22. Tateda, K., T. A. Moore, M. W. Newstead, W. C. Tsai, X. Zeng, J. C. Deng, G. Chen, R. Reddy, K. Yamaguchi, and T. J. Standiford. 2001. Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect. Immun. 69: 2017-2024.
23. Williams, A. E., and R. C. Chambers. 2014. The mercurial nature of neutrophils: still an enigma in ARDS? Am. J. Physiol. Lung Cell. Mol. Physiol. 306: L217-L230.
24. Winter, C., W. Herbold, R. Maus, F. Länger, D. E. Briles, J. C. Paton, T. Welte, and U. A. Maus. 2009. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae. J. Immunol. 182: 4931-4937.
25. Doerschuk, C. M. 2001. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8: 71-88.
26. Bhowmick, R., N. H. Tin Maung, B. P. Hurley, E. B. Ghanem, K. Gronert, B. A. McCormick, and J. M. Leong. 2013. Systemic disease during Streptococcus pneumoniae acute lung infection requires 12-lipoxygenase-dependent inflammation. J. Immunol. 191: 5115-5123.
27. Zemans, R. L., N. Briones, M. Campbell, J. McClendon, S. K. Young, T. Suzuki, I. V. Yang, S. De Langhe, S. D. Reynolds, R. J. Mason, et al. 2011. Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling. Proc. Natl. Acad. Sci. USA 108: 15990-15995.
28. Garcia, J. G., A. Siflinger-Birnboim, R. Bizios, P. J. Del Vecchio, J. W. Fenton, II, and A. B. Malik. 1986. Thrombin-induced increase in albumin permeability across the endothelium. J. Cell. Physiol. 128: 96-104.
29. Bhatia, M., A. K. Saluja, B. Hofbauer, H. S. Lee, J. L. Frossard, and M. L. Steer. 1998. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int. J. Pancreatol. 24: 77-83.
30. Tomizawa, N., S. Ohwada, T. Ohya, I. Takeyoshi, T. Ogawa, Y. Kawashima, M. Adachi, and Y. Morishita. 1999. The effects of a neutrophil elastase inhibitor (ONO-5046.Na) and neutrophil depletion using a granulotrap (G-1) column on lung reperfusion injury in dogs. J. Heart Lung Transplant. 18: 637-645.
31. Chignard, M., and V. Balloy. 2000. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L1083-L1090.
32. Koma, T., K. Yoshimatsu, N. Nagata, Y. Sato, K. Shimizu, S. P. Yasuda, T. Amada, S. Nishio, H. Hasegawa, and J. Arikawa. 2014. Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice. J. Virol. 88: 7178-7188.
33. Raj, J. U., and R. D. Bland. 1983. Neutrophil depletion does not prevent oxygen-induced lung injury in rabbits. Chest 83(5, Suppl.): 20S-21S.
34. Gavett, S. H., M. C. Carakostas, L. A. Belcher, and D. B. Warheit. 1992. Effect of circulating neutrophil depletion on lung injury induced by inhaled silica particles. J. Leukoc. Biol. 51: 455-461.
35. Martin, T. R., B. P. Pistorese, E. Y. Chi, R. B. Goodman, and M. A. Matthay. 1989. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84: 1609-1619.
36. Bastarache, J. A., S. C. Sebag, J. K. Clune, B. S. Grove, W. E. Lawson, D. R. Janz, L. J. Roberts, II, R. Dworski, N. Mackman, and L. B. Ware. 2012. Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax 67: 1032-1039.
37. Scotton, C. J., M. A. Krupiczojc, M. Königshoff, P. F. Mercer, Y. C. G. Lee, N. Kaminski, J. Morser, J. M. Post, T. M. Maher, A. G. Nicholson, et al. 2009. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest. 119: 2550-2563.
38. Mercer, P. F., R. H. Johns, C. J. Scotton, M. A. Krupiczojc, M. Königshoff, D. C. J. Howell, R. J. McAnulty, A. Das, A. J. Thorley, T. D. Tetley, et al. 2009. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179: 414-425.
39. Kallis, Y. N., C. J. Scotton, A. C. Mackinnon, R. D. Goldin, N. A. Wright, J. P. Iredale, R. C. Chambers, and S. J. Forbes. 2014. Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages. PLoS ONE 9: e86241. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086241.
40. Yufu, T., K. Hirano, D. Bi, M. Hirano, J. Nishimura, Y. Iwamoto, and H. Kanaide. 2005. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25: 1506-1511.
41. Tellez, C., and M. Bar-Eli. 2003. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22: 3130-3137.
42. Bar-Shavit, R., H. Turm, Z. Salah, M. Maoz, I. Cohen, E. Weiss, B. Uziely, and S. Grisaru-Granovsky. 2011. PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway. IUBMB Life 63: 397-402.
43. Poole, R. M., and S. Elkinson. 2014. Vorapaxar: first global approval. Drugs 74: 1153-1163.
44. Kaplanski, G., V. Marin, M. Fabrigoule, V. Boulay, A. M. Benoliel, P. Bongrand, S. Kaplanski, and C. Farnarier. 1998. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 92: 1259-1267.
45. Chin, A. C., W. Y. Lee, A. Nusrat, N. Vergnolle, and C. A. Parkos. 2008. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J. Immunol. 181: 5702-5710.
46. Feistritzer, C., and M. Riewald. 2005. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 cross-activation. Blood 105: 3178-3184.
47. Niessen, F., C. Furlan-Freguia, J. A. Fernández, L. O. Mosnier, F. J. Castellino, H. Weiler, H. Rosen, J. H. Griffin, and W. Ruf. 2009. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 113: 2859-2866.
48. Singleton, P. A., L. Moreno-Vinasco, S. Sammani, S. L. Wanderling, J. Moss, and J. G. N. Garcia. 2007. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am. J. Respir. Cell Mol. Biol. 37: 222-231.
49. Kaneider, N. C., A. J. Leger, A. Agarwal, N. Nguyen, G. Perides, C. Derian, L. Covic, and A. Kuliopulos. 2007. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat. Immunol. 8: 1303-1312.
50. Strande, J. L. 2008. Letter by Strande regarding article "Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy." Circulation 117: e495.
51. Schouten, M., C. van't Veer, J. J. Roelofs, M. Levi, and T. van der Poll. 2012. Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study. Crit. Care 16: R238.
52. Coughlin, S. R. 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3: 1800-1814.
53. Jones, M. R., B. T. Simms, M. M. Lupa, M. S. Kogan, and J. P. Mizgerd. 2005. Lung NF-κB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J. Immunol. 175: 7530-7535.
54. Marriott, H. M., K. A. Gascoyne, R. Gowda, I. Geary, M. J. H. Nicklin, F. Iannelli, G. Pozzi, T. J. Mitchell, M. K. B. Whyte, I. Sabroe, and D. H. Dockrell. 2012. Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages. Infect. Immun. 80: 1140-1149.
55. Ortiz-Stern, A., X. Deng, N. Smoktunowicz, P. F. Mercer, and R. C. Chambers. 2012. PAR-1-dependent and PAR-independent pro-inflammatory signaling in human lung fibroblasts exposed to thrombin. J. Cell. Physiol. 227: 3575-3584.
56. Riewald, M., R. J. Petrovan, A. Donner, B. M. Mueller, and W. Ruf. 2002. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880-1882.
57. Gauthier, J.-F., A. Fortin, Y. Bergeron, M.-C. Dumas, M.-E. Champagne, and M. G. Bergeron. 2007. Differential contribution of bacterial N-formylmethionyl-leucyl-phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia. Infect. Immun. 75: 5361-5367.